Human type II phospholipase A(2)-induced Mac-1 expression on human neutrophils

被引:15
作者
Takasaki, J
Kawauchi, Y
Yasunaga, T
Masuho, Y
机构
[1] Molec. Med. Research Laboratory III, Inst. for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., Tsukubu, Ibaraki
[2] Molecular Medicine Research Lab. III, Inst. for Drug Discovery Research, Yamanaouchi Pharmaceutical Co., Ltd., Tsukuba, Ibaraki 305
关键词
CD11b/CD18; leukotriene B-4; AA861; alkaline phosphatase;
D O I
10.1002/jlb.60.2.174
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To investigate the effect of type II phospholipase A(2) (PLA(2)-II) on neutrophil function, we assessed the Mac-1 (CD11b/CD18) expression on human neutrophils by flaw cytometry after incubation of the cells with human PLA(2)-II, PLA(2)-II at a concentration of 10 mu g/mL increased the Mac-1 expression by 150% compared wit unstimulated cells at 30 min and after. Under these conditions PLA(2)-II increased the exocytosis from secretory vesicles but not from azurophilic, specific, or gelatinase granules. The results suggest that PLA(2)-II induces translocation of Mac-1 from the secretory vesicles to the plasma membrane. The Mac-1 induction mediated by PLA(2)-II was inhibited by an anti-PLA(2)-II antibody, which was able to inhibit the catalytic activity. However, the Mac-1 induction by PLA(2)-II was not inhibited by a 5-lipoxygenase, cyclooxygenase inhibitor, or a platelet-activating factor antagonist. Thus, we examined the effects of fatty acids and lysophospholipids oil Mac-1 expression, Only arachidonic acid induced Mac-1 expression. These results imply that PLA(2)-II induces Mac-1 expression oil neutrophils via production of arachidonic acid.
引用
收藏
页码:174 / 180
页数:7
相关论文
共 31 条
  • [1] ABRAMSON SB, 1991, J IMMUNOL, V147, P231
  • [2] EFFECTS OF SCALARADIAL, A NOVEL INHIBITOR OF 14 KDA PHOSPHOLIPASE A(2), ON HUMAN NEUTROPHIL FUNCTION
    BARNETTE, MS
    RUSH, J
    MARSHALL, LA
    FOLEY, JJ
    SCHMIDT, DB
    SARAU, HM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) : 1661 - 1667
  • [3] BERGER M, 1988, BLOOD, V71, P151
  • [4] BOMALASKI JS, 1991, J IMMUNOL, V146, P3904
  • [5] A MODIFIED PROCEDURE FOR DETERMINATION OF LEUKOCYTE ALKALINE PHOSPHATASE
    DECHATELET, LR
    COOPER, MR
    [J]. BIOCHEMICAL MEDICINE, 1970, 4 (01): : 61 - +
  • [6] SPECIFICITY OF EXPRESSION AND EFFECTS OF EICOSANOID MEDIATORS IN NORMAL PHYSIOLOGY AND HUMAN-DISEASES
    GOETZL, EJ
    AN, SZ
    SMITH, WL
    [J]. FASEB JOURNAL, 1995, 9 (11) : 1051 - 1058
  • [7] RECEPTOR-BINDING CAPABILITY OF PANCREATIC PHOSPHOLIPASE-A2 IS SEPARABLE FROM ITS ENZYMATIC-ACTIVITY
    ISHIZAKI, J
    KISHINO, J
    TERAOKA, H
    OHARA, O
    ARITA, H
    [J]. FEBS LETTERS, 1993, 324 (03) : 349 - 352
  • [8] ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897
  • [9] JACOBSON PB, 1993, J IMMUNOL, V151, P5639
  • [10] PREPARATION AND CHARACTERIZATION OF HUMAN RHEUMATOID ARTHRITIC SYNOVIAL-FLUID PHOSPHOLIPASE A(2) PRODUCED BY RECOMBINANT BACULOVIRUS-INFECTED INSECT CELLS
    KAWAUCHI, Y
    TAKASAKI, J
    MATSUURA, Y
    MASUHO, Y
    [J]. JOURNAL OF BIOCHEMISTRY, 1994, 116 (01) : 81 - 87